文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

凝血病及其纠正对脓毒症患者感染源控制时间与临床结局的影响

Effects of coagulopathy and its correction on time to source control and clinical outcomes in patients with sepsis.
PubMed 文献 · Am J Emerg Med · 2025-07-24
一句话结论脓毒症凝血病患者行腹部影像学干预前纠正凝血病与感染源控制延迟及28天死亡率升高相关,未减少大出血并发症。

这项回顾性队列研究利用某三级医院急诊科前瞻性收集的脓毒症登记数据,纳入2011年1月至2020年12月期间接受腹部影像学干预的成人脓毒症或脓毒性休克患者。凝血病定义为PT-INR > 1.5或血小板计数 <50,000/μL。主要结局为28天死亡率。597例患者中161例(27.0%)存在凝血病,其中55例(34.2%)在干预前接受了纠正。纠正组干预中位时间显著更长(15.3 vs. 6.0小时,P < 0.001),28天死亡率更高(41.8% vs. 22.6%,P = 0.02),但大出血并发症无减少。多变量分析显示,纠正凝血病与更高的28天死亡率独立相关(OR 2.52;95%CI 1.13-5.66,P = 0.03),与大出血并发症发生率无关(OR 1.80;95%CI 0.83-3.90,P = 0.13)。

要点

  • 脓毒症凝血病患者行腹部影像学干预前纠正凝血病者28天死亡率41.8%,未纠正者22.6%(P = 0.02)。
  • 纠正凝血病与28天死亡率升高独立相关(OR 2.52;95%CI 1.13-5.66,P = 0.03)。
  • 纠正凝血病未降低大出血并发症(OR 1.80;95%CI 0.83-3.90,P = 0.13)。
  • 纠正组干预中位时间15.3小时,未纠正组6.0小时(P < 0.001)。
  • 凝血病定义为PT-INR > 1.5或血小板计数 <50,000/μL。

适用人群与场景

  • 成人脓毒症或脓毒性休克患者,于2011年1月至2020年12月期间在三级医院急诊科接受腹部影像学干预。

诊断标准与关键阈值

  • 凝血病定义为PT-INR > 1.5或血小板计数 <50,000/μL。

研究设计与关键结果

  • 回顾性队列研究,利用前瞻性收集的脓毒症登记数据;共分析597例患者,其中161例(27.0%)存在凝血病,55例(34.2%)在干预前接受了凝血病纠正。
  • 纠正组干预中位时间15.3小时 vs. 未纠正组6.0小时(P < 0.001)。
  • 纠正组28天死亡率41.8% vs. 未纠正组22.6%(P = 0.02)。
  • 多变量分析:纠正凝血病与28天死亡率升高独立相关(OR 2.52;95%CI 1.13-5.66,P = 0.03),与大出血并发症无关(OR 1.80;95%CI 0.83-3.90,P = 0.13)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在脓毒症凝血病患者接受腹部影像学干预时,纠正凝血病与感染源控制延迟和28天死亡率升高相关,且未减少大出血并发症。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Radiological intervention is often required for infection source control in sepsis, and correcting coagulopathy prior to procedures with bleeding risk is recommended. This study aimed to evaluate the impacts of correcting coagulopathy on time to intervention and on 28-day mortality in patients with sepsis undergoing abdominal radiological interventions.

METHODS: This retrospective cohort study utilized prospectively collected sepsis registry from the emergency department of a tertiary hospital. Adult patients with sepsis or septic shock who underwent abdominal radiological intervention between January 2011 and December 2020 were included. Coagulopathy was defined as PT-INR > 1.5 or platelet count <50,000/μL. The primary outcome was 28-day mortality, and secondary outcome included major bleeding complications, requiring transfusion, embolization or surgery. Multivariable logistic regression was performed to identify independent associations.

RESULTS: Among the 597 patients analyzed, 161 (27.0 %) had coagulopathy. Among these, 55 (34.2 %) underwent correction prior to intervention. Patients who underwent correction had a significantly longer median time to intervention (15.3 vs. 6.0 h, P < 0.001) and higher 28-day mortality (41.8 % vs. 22.6 %, P = 0.02), but no reduction in major bleeding complications was achieved. In multivariable analysis, coagulopathy correction associated independently with a higher 28-day mortality rate (OR, 2.52; 95 % CI, 1.13-5.66, P = 0.03) but not with the incidence of major bleeding complications (OR 1.80; 95 % CI, 0.83-3.90, P = 0.13).

CONCLUSIONS: In septic patients with coagulopathy undergoing abdominal radiological intervention, coagulopathy correction correlated with delayed source control and increased 28-day mortality, without reducing major bleeding complications.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Jo Y, Kang SH, Hwang JE, et al. Effects of coagulopathy and its correction on time to source control and clinical outcomes in patients with sepsis. Am J Emerg Med. 2025. PMID: 40716242. doi:10.1016/j.ajem.2025.07.048

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。